Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Maintain BUY on Axis Bank - Provision buffers strengthened (further) - HDFC Securities

Posted On: 2020-10-29 05:49:03 (Time Zone: Arizona, USA)


Mr. Darpin Shah, Institutional Research Analyst, HDFC Securities

We maintain BUY on AXSB with a target price of Rs 616. AXSB saw strong operating profit growth, led by robust NII growth, a sequential rebound in core fees, and controlled operating costs. Even as we expect the bank to register a rise in GNPAs in FY21E, it has already built significant provision buffers, which will limit the need for incremental provisioning. Further, strength on the funding side (CRAR and deposit traction) will allow the bank to capture resurgent credit growth.

Asset quality trends: Reported GNPAs declined 85/54bps to 4.2%. Adjusted for the impact of the SC order, GNPAs were 4.3%. Overall collection efficiency improved to ~95% in Sept-20 and further to ~97% in Oct-20. The pool of BB and below-rated loans grew ~37% QoQ to constitute ~2.6% of loans, led by voluntary downgrades. The management expects to restructure ~1.6% of loans. We continue to build in a rise in GNPAs in FY21E to 5.3%.

Non-tax provisions remained elevated at Rs 45.8bn (+30.2/3.7%). In addition to specific provisions covering ~88% of GNPAs, AXSB held provisions of ~Rs 108bn (1.9%) including contingent provisions, provisions against anticipated restructuring (Rs 18.6bn), and COVID-19 related provisions of Rs 50.1bn. Together, these constitute a significant buffer to absorb future stress. Nevertheless, we continue to model LLPs of 1.7% over FY21-23E.

Deposit growth was relatively tepid at 8.8/1.2%. However, the bank saw strong CASA growth at 17.0/9.4%. Consequently, the CASA ratio rose to 44.2% (+308/331bps). This partly contributed to a significant fall in the CoF (-125/-36bps) to 4.4%. Post the recent fundraise, CRAR stood at 19.4%.

Loan growth came in at 10.5/2.7%. Sequential growth was led by the SME segment (+6%, albeit -1% YoY), which in turn was led by disbursals under the credit guarantee scheme (Rs 60bn disbursed). At 11.9/2.4, the bank's retail portfolio witnessed broad-based growth while its corporate portfolio grew 12.4/2.2%. Funding side capabilities will allow the bank to capture resurgent growth. We model a 13% loan CAGR over FY21-23E.

Shares of AXIS BANK LTD. was last trading in BSE at Rs.493.7 as compared to the previous close of Rs. 504.85. The total number of shares traded during the day was 1562834 in over 32531 trades.

The stock hit an intraday high of Rs. 516.25 and intraday low of 489.5. The net turnover during the day was Rs. 783969327.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Maintain ADD on Symphony - Domestic in line; RoW improving - HDFC Securities

Maintain ADD on Multi Commodity Exchange - Taking a pause; recovery awaited - HDFC Securities

Maintain ADD on DCB Bank - Provisioning cushion emerges ahead of expectations - HDFC Securities

Maintain BUY on Birla Corporation - Margin buoyancy continues - HDFC Securities

ADD on SRF - Returning to normalcy - HDFC Securities

HDFC Securities - Maintain BUY on UltraTech Cement - Solid show!

Ajanta Pharma (Initiating Coverage) - Gearing for the next leap - HDFC Securities

BUY on SBI Life Insurance - Growth returns - HDFC Securities

Kajaria Ceramics (Initiating Coverage) - Galloping ahead - HDFC Securities

UltraTech Q3 FY21 - YES Securities

HDFC Life Q3 FY21 - YES Securities

SBI Life - Q3 FY21 - YES Securities

Aavas Financiers Q3 FY21 - Conference Call Takeaways - YES Securities

Birla Corp Q3 FY21 - YES Securities

ADD on Reliance Industries - Sailed through the tough times! - HDFC Securities

Grasim Industries - Aspiring for strong no.2 position in paints - ICICI Securities

Kewal Kiran Clothing - Better execution with flat EBITDA YoY - ICICI Securities

Mphasis - DXC will continue to be key in the near term - ICICI Securities

HDFC Securities: Indian Chemical Sector (Sector Update) - Steering well through the pandemic!

UltraTech Cement - Earnings upgrade continues; ripe for rerating - ICICI Securities

Multi Commodity Exchange of India - Lower turnover impacted operating performance - Q3FY21 - ICICI Securities

SBI Life Insurance Company - Strong performance, attractive valuations (<2 FY23 P/EV) - ICICI Securities

Biocon Limited - Slow recovery in biosimilars - ICICI Securities

HDFC Life Insurance Company - Not only - but also - about protection - ICICI Securities

DCB Bank - Gradually approaching normalcy - ICICI Securities

Aurobindo Pharma - Approval for 3 products under PLI Scheme - ICICI Securities

Yes Bank - Aggravating asset quality fears outweigh operating performance turnaround - ICICI Securities

JSW Steel - Peak margins expected in Q4FY21 - ICICI Securities

Aavas Financiers - Quality intact; premium to sustain - ICICI Securities

Supreme Industries - Q3FY21 First Cut - ICICI Direct

Polycab India Ltd - Q3FY21 First Cut - ICICI Direct

DCB Bank - Q3FY21 First Cut - ICICI Direct

Q3FY21 Result update - Symphony Ltd. - ICICI Direct

Ultratech Cement - Q3FY21 First Cut - ICICI Direct

Oberoi Realty - Q3FY21 First Cut - ICICI Direct

HDFC Life Insurance - Q3FY21 First Cut - ICICI Direct

SRF Limited - Chemical biz's good performance may continue - ICICI Securities

Multi Commodity Exchange of India - Lower turnover impacted operating performance - ICICI Securities

Q3FY21 Company update - Zensar Technologies - ICICI Direct

JSW Steel - Q3FY21 First Cut - ICICI Direct

Q3FY21 Result update - Biocon Ltd - ICICI Direct

Symphony Ltd - Q3FY21 First Cut - ICICI Direct

Crompton Greaves Consumer Electricals - Q3FY21 First Cut - ICICI Direct

Q3FY21 Result update - Bajaj Finserv - ICICI Direct

Q3FY21 Result update - Bajaj Auto - ICICI Direct

Quant Pick - Hero MotoCorp - ICICI Direct

Company update - Cyient Ltd - Q3FY21 - ICICI Direct

Covid Recovery Pulse - Auto retail taper off in new year 2021 - ICICI Direct

Q3FY21 Result update - Asian Paints - ICICI Direct

Company update - Mphasis Ltd - Q3FY21 - ICICI Direct



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020